Indexed logomarkindexed.vc

Adial Pharmaceuticals

IPO

Public · $64.0M raised

Biotech
Drug Discovery
Healthcare
Website
adial.com
Total Funding
$64.0M
Last Round
$64.0M Corporate RoundJun 2026
Rounds
1
Type
Public
Ticker
ADIL · NASDAQ

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Adial Pharmaceuticals develops drug candidates for Alcohol Use Disorder and ulcerative colitis. Its pipeline includes AT177, a colon-targeted aryl hydrocarbon receptor agonist in development for ulcerative colitis, and AD04, a genetically targeted serotonin-3 receptor antagonist. AD04 is being advanced through a new Phase 3 clinical-trial program for Alcohol Use Disorder in patients with specified target genotypes.

Summary

Adial Pharmaceuticals is a Biotech company. It has raised $64.0M in total across 1 round, most recently a $64.0M Corporate Round in Jun 2026.

LinkedInX (Twitter)

Funding History

Corporate RoundCorporate RoundJun 2026
$64.0M

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Adial Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/adial-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/adial-pharmaceuticals" alt="Adial Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>